,,iii  #aac? ,,congress  #b;d ,session  
,s4 ,,res4 #cic  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,m>* #bd1 #bjad ,mr4  
,br[n 7= himself & ,mr4 ,isakson7       
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,=eign        
,relations  ,,resolution  ,support+ !   
goals ( ,_w ,tub]culosis ,day to raise  
aw>5ess ab\t tub]culosis4  ,:]eas #a_/c 
( ! population ( ! _w is infect$ ) !    
tub]culosis bact]ium2 ,:]eas m ?an      
#i1ejj tub]culosis cases 7 report$ 9 !  
,unit$ ,/ates 9 #bjac2 ,:]eas m ?an     
#a1cjj1jjj individuals die f tub]culosis
 ea* ye>2 ,:]eas ov] #ie p]c5t (        
tub]culosis dea?s occur 9 l[- &         
middle-income develop+ c\ntries2 ,:]eas 
tub]culosis is ! second lead+ global    
infecti\s disease kill]1 beh9d          
,,hiv_/,,aids1 & claims #a1hjj1jjj lives
 ea* ye>2 ,:]eas tub]culosis is a lead+ 
kill] ( p liv+ ) ,,hiv_/,,aids1 caus+   
#a_/e ( all dea?s among p )             
,,hiv_/,,aids2 ,:]eas tub]culosis is !  
?ird lead+ kill] ( adult wom51 & ! /igma

 associat$ ) tub]culosis                
disproportionately affects wom51 caus+  
wom5 to delay seek+ c>e & int]f]+ )     
treatm5t adh]5ce2 ,:]eas ! global       
tub]culosis p&emic & ! spread (         
drug-resi/ant tub]culosis pres5t a      
p]si/5t public heal? ?reat to ! ,unit$  
,/ates2 ,:]eas accord+ to #bjji data f !
 ,_w ,heal? ,organization1 #c4f p]c5t ( 
all new tub]culosis cases are drug      
resi/ant2 ,:]eas multi-drug resi/ant    
tub]culosis 7ref]r$ to 9 ?is preamble z 
,,mdr-,,tb7 is pres5t 9 virtually all   
c\ntries survey$2 ,:]eas approximately  
#dej1jjj p ar\nd ! _w develop$          
,,mdr-,,tb 9 #bjab2 ,:]eas ext5sively   
drug-resi/ant tub]culosis 7ref]r$ to 9  
?is preamble z ,,xdr-,,tb7 is a /ra9 (  
tub]culosis t is v difficult & exp5sive 
to treat & has high & rapid fatality    
rates1 especially among ,,hiv_/,,aids   
pati5ts2 ,:]eas !re h be5 m ?an #fc     
cases ( ,,xdr-,,tb 9 ! ,unit$ ,/ates    
betwe5 #bjjd & #bjad2 ,:]eas z (        
,septemb] #bjac1 #ib c\ntries h report$ 

at lea/ #a case ( ,,xdr-,,tb2 ,:]eas !  
,c5t]s = ,disease ,control & ,prev5tion 
e/imat$1 9 #bjji1 t ! co/ ( hospitaliz+ 
a s+le pati5t ) ,,xdr-,,tb is #dhc1jjj2 
,:]eas1 betwe5 #bjje & #bjjg1 ! #cgc    
,,xdr-,,tb cases 9 ! ,unit$ ,/ates      
collectively co/ ! heal? c>e sy/em an   
e/imat$ #ec1jjj1jjj2 ,:]eas ! dea? rate 
( tub]culosis dropp$ #de p]c5t betwe5   
#aiij & #bjab2 ,:]eas ! ,in/itute (     
,m$ic9e f\nd t a decrease 9 tub]culosis 
control fund+ & ! spread ( ,,hiv_/,,aids
 caus$ ! resurg5ce ( tub]culosis betwe5 
#aihj & #aiib2 ,:]eas al?\gh ! numb] (  
tub]culosis cases 9 ! ,unit$ ,/ates     
cont9ues to decl9e1 progress t[>ds      
elim9at+ tub]culosis has sl[$ & !       
disease does n recognize bord]s2 ,:]eas 
,african ,am]icans are #h times m likely
 to h tub]culosis ?an ,caucasians1 &    
significant disp>ities exi/ among o!r   
m9orities 9 ! ,unit$ ,/ates1 includ+    
,native ,am]icans1 ,asian ,am]icans1 &  
,hispanic ,am]icans2 ,:]eas ov] #ecj1jjj
 *ildr5 became infect$ ) tub]culosis 9  

#bjab2 ,:]eas tobacco use greatly       
increases ! risk ( tub]culosis & dea?1 &
 m ?an #bj p]c5t ( tub]culosis cases    
worldwide are attribut$ to smok+2 ,:]eas
 diabetes is a major risk factor =      
tub]culosis1 & p ) diabetes are m likely
 to develop ! disease & h a high] risk (
 dea? due to ! disease2 ,:]eas a new    
te*nology1 kn[n z ,xp]t1 develop$ 9 !   
,unit$ ,/ates1 is able to diagnose cases
 ( tub]culosis )9 #b h\rs1 & su*        
te*nology c ev5 diagnose cases t are    
difficult to detect1 su* z cases involv+
 individuals liv+ ) ,,hiv2 ,:]eas al?\gh
 drugs1 diagno/ics1 & vacc9es =         
tub]culosis exi/1 ^! te*nologies are    
antiquat$ & increas+ly inadequate =     
controll+ ! global epidemic2 ,:]eas     
,xp]t c quickly detect resi/ance to #a (
 ! prim>y tub]culosis drugs1 b o!r te/s 
to detect drug resi/ance take at lea/ #a
 mon? to complete & ! m$ical community  
mu/ develop ev5 fa/] drug susceptibility
 te/s to /op ! spread ( drug-resi/ant   
tub]culosis2 ,:]eas ,bacillus           

,calmette-,gur91 a tub]culosis vacc9e t 
is kn[n z ,,bcg1 provides "s protection 
to *ildr5 b has little or no efficacy 9 
prev5t+ pulmon>y tub]culosis 9 adults2  
,:]eas !re is a critical ne$ = !        
developm5t ( tub]culosis drugs t        
individuals c safely take concurr5tly ) 
antiretroviral !rapy = ,,hiv2 ,:]eas !  
,mill5nium ,developm5t ,goal ( ! ,_w    
,heal? ,organization is to rev]se !     
spread ( tub]culosis by #bjae2 ,:]eas ! 
enactm5t ( ! ,tom ,lantos & ,h5ry ,j4   
,hyde ,unit$ ,/ates ,global ,lead]%ip   
,aga9/ ,,hiv_/,,aids1 ,tub]culosis1 &   
,mal>ia ,reau?orization ,act ( #bjjh    
7,public ,law #aaj-bic2 #abb ,/at4      
#biah7 & ! ,compreh5sive ,tub]culosis   
,elim9ation ,act ( #bjjh 7,public ,law  
#aaj-cib2 #abb ,/at4 #daie7 provides a  
hi/oric ,unit$ ,/ates commitm5t to !    
global eradication ( tub]culosis1       
includ+ a commitm5t to successfully     
treat+ #d1ejj1jjj tub]culosis pati5ts & 
#ij1jjj ,,mdr-,,tb pati5ts betwe5 #bjjh 
& #bjac & to provid+ additional treatm5t

 ?r\gh coord9at$ multilat]al ef=ts2     
,:]eas ! ,unit$ ,/ates ,ag5cy =         
,int]national ,developm5t provides      
f9ancial & te*nical assi/ance to ne>ly  
#dj highly burd5$ tub]culosis c\ntries1 
supports ! developm5t ( new diagno/ic & 
treatm5t tools1 & is au?oriz$ to support
 rese>* to develop new vacc9es to combat
 tub]culosis2 ,:]eas ! ,c5t]s = ,disease
 ,control & ,prev5tion1 p>tn]+ ) ! o!r  
entities ( ! ,unit$ ,/ates & individual 
,/ates & t]ritories1 directs ! national 
tub]culosis elim9ation program1 directs 
ess5tial national tub]culosis           
surveillance1 te*nical assi/ance1 &     
prev5tion activities1 & supports !      
developm5t ( new diagno/ic1 treatm5t1 & 
prev5tion tools to combat tub]culosis2  
,:]eas ! ,national ,in/itutes ( ,heal?1 
?r\gh its _m in/itutes & c5t]s1 plays ! 
lead+ role 9 basic & cl9ical rese>* on !
 id5tification1 treatm5t1 & prev5tion ( 
tub]culosis2 ,:]eas ! ,global ,fund to  
,fight ,,aids1 ,tub]culosis1 & ,mal>ia  
provides #fc p]c5t ( all int]national   

f9anc+ = tub]culosis programs2 ,:]eas ! 
,global ,fund to ,fight ,,aids1         
,tub]culosis1 & ,mal>ia f9ances-- 7#a7  
proposals wor? #c1bjj1jjj1jjj 9 #aab    
c\ntries2  7#b7 tub]culosis treatm5t =  
#f1jjj1jjj p2 &  7#c7 #a1hjj1jjj        
,,hiv_/,,aids & tub]culosis s]vices2    
,:]eas ! preval5ce & mortality rates (  
tub]culosis are decl9+ 9 _m c\ntries )  
programs support$ by ! ,global ,fund to 
,fight ,,aids1 ,tub]culosis1 & ,mal>ia2 
& ,:]eas ,m>* #bd1 #bjad1 is ,_w        
,tub]culosis ,day1 a day t commemorates 
! date 9 #ahhb on :i* ,dr4 ,rob]t ,ko*  
ann\nc$ 8 discov]y ( ,mycobact]ium      
tub]culosis1 ! bact]ia t causes         
tub]culosis3 ,n[1 !re=e1 be x  ,t !     
,s5ate-- 7#a7 supports ! goals ( ,_w    
,tub]culosis ,day to raise aw>5ess ab\t 
tub]culosis2  7#b7 comm5ds ! progress ( 
anti-tub]culosis ef=ts by entities t    
include ! ,unit$ ,/ates ,ag5cy =        
,int]national ,developm5t1 ! ,c5t]s =   
,disease ,control & ,prev5tion1 !       
,national ,in/itutes ( ,heal?1 & !      

,global ,fund to ,fight ,,aids1         
,tub]culosis1 & ,mal>ia2 &  7#c7        
reaffirms ! commitm5t to global         
tub]culosis control set =? 9 section #d 
( ! ,unit$ ,/ates ,lead]%ip ,aga9/      
,,hiv_/,,aids1 ,tub]culosis1 & ,mal>ia  
,act ( #bjjc 7#bb ,u4,s4,c4 #gfjc74